Streetbeat News

CPT

Camden Property Trust

https://www.camdenliving.com

Industry

REIT - Residential

Camden Property Trust, an S&P 400 Company, is a real estate company primarily engaged in the ownership, management, development, redevelopment, acquisition, and construction of multifamily apartment communities. Camden owns interests in and operates 167 properties containing 56,850 apartment homes across the United States. Upon completion of 7 properties currently under development, the Company's portfolio will increase to 59,104 apartment homes in 174 properties. Camden has been recognized as one of the 100 Best Companies to Work For® by FORTUNE magazine for 13 consecutive years, most recently ranking #18. The Company also received a Glassdoor Employees' Choice Award in 2020, ranking #25 for large U.S. companies.

Open

112.57

Mkt cap

12B

Volume

888K

High

112.91

P/E Ratio

35.52

52-wk high

127.69

Low

111.75

Div yield

0.04

52-wk low

90.50

Camden Property Trust announced that its Los Angeles apartment communities were not damaged by recent wildfires and is prepared to assist those affected with housing.

Portfolio Pulse from

January 10, 2025 | 10:45 pm

Camden Property Trust (NYSE:CPT) is responding to a Department of Justice lawsuit that includes them as a defendant in a case against RealPage. Camden plans to defend itself and seek dismissal of the claims.

Portfolio Pulse from

January 08, 2025 | 1:00 am

Camden Property Trust is recognized for its strong management, growth history, and consistent dividend increases, recently announcing a dividend of $1.03 per share. Despite potential risks like overdevelopment and rising interest rates, Camden is considered undervalued by 11-13% based on historical yields, with an expected annual return of 8.78% according to the Chowder Rule.

Portfolio Pulse from

December 24, 2024 | 11:00 am

Envoy Medical has reported its third quarter 2024 results, highlighting two significant developments: FDA approval to begin a pivotal trial for a fully implanted cochlear implant and AMA approval of CPT codes for its FDA-approved fully implanted middle ear implant.

Portfolio Pulse from

November 14, 2024 | 2:00 pm

Camden Property Trust (CPT), a leading multifamily REIT, is poised to benefit from improving market fundamentals such as strong demand, rent growth, and reduced new construction, despite recent stock price declines due to market volatility.

Portfolio Pulse from

November 06, 2024 | 7:30 am

Camden Property Trust has updated its financial outlook for 2024, lowering its EPS forecast from $1.88 to $1.48, slightly reducing its FFO outlook from $6.72 to $6.69, and raising its Core FFO outlook from $6.79 to $6.81.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 11:13 am

Camden Property Trust reported Q3 2024 earnings per share of $0.33, missing the analyst estimate of $0.37. Sales were $387.20 million, slightly below the $389.39 million estimate and down 0.92% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:20 pm

Camden Property Trust reported minor damage from Hurricanes Helene and Milton. The company will provide updates if there are any material changes.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 8:17 pm

Jefferies has initiated coverage on Camden Property Trust (NYSE:CPT) with a Hold rating and set a price target of $123.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.